4.6 Article

High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients

Journal

ATHEROSCLEROSIS
Volume 215, Issue 1, Pages 116-124

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2010.11.038

Keywords

Chronic kidney disease; Cardiovascular outcomes; Mortality; Tenascin-C

Funding

  1. Picardy Regional Council/University of Picardy Jules Verne
  2. National Council of Technological and Scientific Development (CNPq), Brazil

Ask authors/readers for more resources

Objectives: Tenascin-C (TN-C) is an adhesion-modulating extracellular matrix glycoprotein which is over-expressed in various organs under disease conditions (infection and inflammation). In patients with heart disease, plasma TN-C levels have been shown to be predictive of cardiac remodeling. Chronic kidney disease (CKD) is associated with a state of chronic inflammation and high cardiovascular morbidity and mortality. Methods: In a prospective observational study, we examined the relationship between plasma concentration of large splice variants of TN-C (cTN-C) and cardiovascular outcomes, we studied a cohort of 94 prevalent CKD patients (mean + SD age: 68 + 13; 31% at CKD stages 2-3, 31% at stages 4-5, 38% at stage 5D). Results: Plasma cTN-C levels were elevated in this population and tended to rise as CKD progressed, with the increase becoming statistically significant at CKD stage 4-5 and 5D. Multivariate linear regression analysis indicated that CKD stage (p = 0.04), IL-6 (p = 0.02) and albumin (p = 0.02) were independently associated with plasma cTN-C levels. During follow-up (mean duration: 969 +/- 405 days), 32 patients died (19 from CV events, 7 from infectious diseases and 6 from other causes). In a crude analysis, higher plasma cTN-C levels predicted overall and CV mortality (p = 0.007 and p = 0.003, respectively) and were associated with higher occurrence of CV events. Cox analyses confirmed that elevated plasma cTN-C levels were independently associated with cardiovascular events, cardiovascular and overall mortality. Conclusion: Our findings suggest, for the first time, that plasma cTN-C levels are independently associated with cardiovascular outcomes in CKD patients. Further studies are needed in order to confirm the above observations and better understand TN-C's role in cardiovascular remodeling in CKD. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available